Literature DB >> 7985064

Hemorrhoids, fissures, and pruritus ani.

W P Mazier1.   

Abstract

The diagnosis and management of hemorrhoids, fissures, and pruritus ani probably accounts for more than 81% of the complaints centered on this part of the human anatomy. This brief treatise offers a safe and practical approach to the management of these three diseases.

Entities:  

Mesh：

Year:  1994        PMID： 7985064     DOI： 10.1016/s0039-6109(16)46480-7

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN： 0039-6109            Impact factor:   2.741


  7 in total

1.  Long-term results of single intradermal 1 % methylene blue injection for intractable idiopathic pruritus ani: a prospective study.

Authors:  N E Samalavicius; T Poskus; R K Gupta; R Lunevicius
Journal:  Tech Coloproctol       Date:  2012-06-06       Impact factor: 3.781

2.  Hidradenitis suppurativa and pruritus ani.

Authors:  Theodor Asgeirsson; Robert Nunoo; Martin A Luchtefeld
Journal:  Clin Colon Rectal Surg       Date:  2011-03

3.  Topical capsaicin--a novel and effective treatment for idiopathic intractable pruritus ani: a randomised, placebo controlled, crossover study.

Authors:  J Lysy; M Sistiery-Ittah; Y Israelit; A Shmueli; N Strauss-Liviatan; V Mindrul; D Keret; E Goldin
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

Review 4.  Rethinking What We Know About Hemorrhoids.

Authors:  Robert S Sandler; Anne F Peery
Journal:  Clin Gastroenterol Hepatol       Date:  2018-03-27       Impact factor: 11.382

5.  Botulinum toxin injection versus internal anal sphincterotomy for the treatment of chronic anal fissure.

Authors:  Baghai-Wadji Massoud; Vahedian Mehrdad; Tolooie Baharak; Zohoor Alireza
Journal:  Ann Saudi Med       Date:  2005 Mar-Apr       Impact factor: 1.526

Review 6.  Symptoms in Dilating Venous Disease.

Authors:  Ertan Yetkin; Selcuk Ozturk; Bilal Cuglan; Hasan Turhan
Journal:  Curr Cardiol Rev       Date:  2020

7.  Relationship between anal symptoms and anal findings.

Authors:  Hans Georg Kuehn; Ole Gebbensleben; York Hilger; Henning Rohde
Journal:  Int J Med Sci       Date:  2009-03-06       Impact factor: 3.738
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.